Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 1
1980 3
1981 1
1982 1
1986 2
1987 1
1988 2
1990 3
1991 1
1992 1
1993 1
1994 3
1996 1
1997 3
1998 1
2000 2
2001 2
2002 1
2003 4
2004 1
2005 6
2006 3
2007 8
2008 8
2009 5
2010 4
2011 2
2012 7
2013 1
2014 1
2015 1
2016 2
2017 4
2018 2
2019 2
2020 1
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
The power and potential of doxorubicin-DNA adducts.
Cutts SM, Nudelman A, Rephaeli A, Phillips DR. Cutts SM, et al. Among authors: rephaeli a. IUBMB Life. 2005 Feb;57(2):73-81. doi: 10.1080/15216540500079093. IUBMB Life. 2005. PMID: 16036566 Free article. Review.
A switch in mechanism of action prevents doxorubicin-mediated cardiac damage.
Cheong A, McGrath S, Robinson T, Maliki R, Spurling A, Lock P, Rephaeli A, Nudelman A, Parker BS, Pepe S, Cutts SM. Cheong A, et al. Among authors: rephaeli a. Biochem Pharmacol. 2021 Mar;185:114410. doi: 10.1016/j.bcp.2021.114410. Epub 2021 Jan 9. Biochem Pharmacol. 2021. PMID: 33428897
A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo.
Tarasenko N, Cutts SM, Phillips DR, Berkovitch-Luria G, Bardugo-Nissim E, Weitman M, Nudelman A, Rephaeli A. Tarasenko N, et al. Among authors: rephaeli a. Biochem Pharmacol. 2014 Mar 15;88(2):158-68. doi: 10.1016/j.bcp.2014.01.023. Epub 2014 Jan 24. Biochem Pharmacol. 2014. PMID: 24463168
The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin.
Moyal L, Feldbaum N, Goldfeiz N, Rephaeli A, Nudelman A, Weitman M, Tarasenko N, Gorovitz B, Maron L, Yehezkel S, Amitay-Laish I, Lubin I, Hodak E. Moyal L, et al. Among authors: rephaeli a. PLoS One. 2016 Jan 11;11(1):e0146115. doi: 10.1371/journal.pone.0146115. eCollection 2016. PLoS One. 2016. PMID: 26752418 Free PMC article.
86 results